HEMSX
Price
$9.29
Change
-$0.10 (-1.06%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

HEMSX vs RNWFX

Header iconHEMSX vs RNWFX Comparison
Open Charts HEMSX vs RNWFXBanner chart's image
Janus Henderson Emerging Markets S
Price$9.29
Change-$0.10 (-1.06%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HEMSX vs RNWFX Comparison Chart
Loading...
VS
HEMSX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEMSX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. HEMSX (29.7M). RNWFX pays higher dividends than HEMSX: RNWFX (1.51) vs HEMSX (0.08). HEMSX was incepted earlier than RNWFX: HEMSX (7 years) vs RNWFX (22 years). HEMSX is a more actively managed with annual turnover of: 63.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than HEMSX: RNWFX (250) vs HEMSX (2500). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. HEMSX (7.90). RNWFX return over 5 years is better than : 22.38 vs. HEMSX (9.48).
HEMSXRNWFXHEMSX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years22 years-
Gain YTD4.7997.24566%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets29.7M60.1B0%
Annual Yield % from dividends0.081.515%
Returns for 1 year7.9011.5369%
Returns for 3 years-24.50-15.44159%
Returns for 5 years9.4822.3842%
Returns for 10 yearsN/A35.71-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio